
Robert W. Downs
Examiner (ID: 17152)
| Most Active Art Unit | 2308 |
| Art Unit(s) | 2762, 4762, 2309, 2308, 2165 |
| Total Applications | 581 |
| Issued Applications | 448 |
| Pending Applications | 24 |
| Abandoned Applications | 109 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18284224
[patent_doc_number] => 20230099696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => NANO-COMPOSITE MICROPARTICLES OF POLYMYXIN
[patent_app_type] => utility
[patent_app_number] => 17/908492
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908492 | NANO-COMPOSITE MICROPARTICLES OF POLYMYXIN | Mar 4, 2021 | Pending |
Array
(
[id] => 18552424
[patent_doc_number] => 20230250433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF APC-DEFICIENT CANCER
[patent_app_type] => utility
[patent_app_number] => 17/905124
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905124 | METHODS AND COMPOSITIONS FOR TREATMENT OF APC-DEFICIENT CANCER | Feb 25, 2021 | Pending |
Array
(
[id] => 16898905
[patent_doc_number] => 20210177821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => Androgen Receptor Modulator And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/185420
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185420 | Androgen Receptor Modulator And Uses Thereof | Feb 24, 2021 | Abandoned |
Array
(
[id] => 18589227
[patent_doc_number] => 11738099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Molecular probes and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/182997
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 44
[patent_no_of_words] => 26730
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182997 | Molecular probes and methods of use | Feb 22, 2021 | Issued |
Array
(
[id] => 16932307
[patent_doc_number] => 20210198196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => NON-AGGREGATING HEPTAMETHINE CYANINE FLUOROPHORES FOR IN VIVO IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/179217
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179217 | Non-aggregating heptamethine cyanine fluorophores for in vivo imaging | Feb 17, 2021 | Issued |
Array
(
[id] => 18252718
[patent_doc_number] => 20230079757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => METHODS AND MATERIALS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/800008
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800008 | METHODS AND MATERIALS FOR TREATING CANCER | Feb 17, 2021 | Abandoned |
Array
(
[id] => 17065917
[patent_doc_number] => 20210268132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => METHODS OF SEQUESTERING TARGET ELEMENTS
[patent_app_type] => utility
[patent_app_number] => 17/175228
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/175228 | METHODS OF SEQUESTERING TARGET ELEMENTS | Feb 11, 2021 | Pending |
Array
(
[id] => 17050767
[patent_doc_number] => 20210260201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => EXTRACELLULAR VESICLES FOR THE TREATMENT AND PREVENTION OF INFECTIONS AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/172293
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172293
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172293 | EXTRACELLULAR VESICLES FOR THE TREATMENT AND PREVENTION OF INFECTIONS AND OTHER DISEASES | Feb 9, 2021 | Abandoned |
Array
(
[id] => 16992172
[patent_doc_number] => 20210230592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors
[patent_app_type] => utility
[patent_app_number] => 17/158132
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/158132 | Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors | Jan 25, 2021 | Abandoned |
Array
(
[id] => 16822797
[patent_doc_number] => 20210138090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => uPAR targeting peptide for use in peroperative optical imaging of invasive cancer
[patent_app_type] => utility
[patent_app_number] => 17/150133
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150133 | uPAR targeting peptide for use in peroperative optical imaging of invasive cancer | Jan 14, 2021 | Abandoned |
Array
(
[id] => 20621677
[patent_doc_number] => 12589171
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => 177-Lu labeled peptide for site-specific uPAR-targeting
[patent_app_type] => utility
[patent_app_number] => 17/144067
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4647
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144067 | 177-Lu labeled peptide for site-specific uPAR-targeting | Jan 6, 2021 | Issued |
Array
(
[id] => 18283728
[patent_doc_number] => 20230099200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT OF CXCR4 EXPRESSING TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/789398
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789398
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789398 | RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT OF CXCR4 EXPRESSING TUMORS | Dec 22, 2020 | Pending |
Array
(
[id] => 17968244
[patent_doc_number] => 11485758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Bi-terminal pegylated integrin-binding peptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/131324
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 37663
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/131324 | Bi-terminal pegylated integrin-binding peptides and methods of use thereof | Dec 21, 2020 | Issued |
Array
(
[id] => 18525505
[patent_doc_number] => 11712485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Triazine based radiopharmaceuticals and radioimaging agents
[patent_app_type] => utility
[patent_app_number] => 17/129825
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16829
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129825 | Triazine based radiopharmaceuticals and radioimaging agents | Dec 20, 2020 | Issued |
Array
(
[id] => 18027840
[patent_doc_number] => 11511001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
[patent_app_type] => utility
[patent_app_number] => 17/127618
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28887
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127618 | Radiolabeled anti-LAG3 antibodies for immuno-PET imaging | Dec 17, 2020 | Issued |
Array
(
[id] => 18341294
[patent_doc_number] => 11638763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Nanoallergens and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/126616
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 84
[patent_no_of_words] => 22464
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 392
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126616 | Nanoallergens and uses thereof | Dec 17, 2020 | Issued |
Array
(
[id] => 18166765
[patent_doc_number] => 20230033370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17
[patent_app_type] => utility
[patent_app_number] => 17/782910
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782910 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 | Dec 15, 2020 | Abandoned |
Array
(
[id] => 18178948
[patent_doc_number] => 20230039677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17
[patent_app_type] => utility
[patent_app_number] => 17/782931
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782931
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782931 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 | Dec 15, 2020 | Abandoned |
Array
(
[id] => 18179279
[patent_doc_number] => 20230040008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
[patent_app_type] => utility
[patent_app_number] => 17/786768
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786768 | ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES | Dec 15, 2020 | Pending |
Array
(
[id] => 16883862
[patent_doc_number] => 20210170057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => HER2 BINDERS
[patent_app_type] => utility
[patent_app_number] => 17/117697
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17117697
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/117697 | HER2 binders | Dec 9, 2020 | Issued |